Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma. (March 2021)
- Record Type:
- Journal Article
- Title:
- Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma. (March 2021)
- Main Title:
- Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma
- Authors:
- Zhang, Li
Song, Mengmeng
Zhang, Fan
Yuan, Hao
Chang, Wenjun
Yu, Guanyu
Niu, Yongdong - Abstract:
- Nicotinamide N -methyltransferase (NNMT), a major metabolic regulator, has been identified as a predictor of cancer prognosis in ovarian and colorectal cancers. The study aims to evaluate the significance of stromal NNMT in gastric cancer (GC). Expression of stromal NNMT in 612 GC and 92 non-malignant tissues specimens was investigated by immunohistochemistry (IHC). The association between NNMT expression and occurrence of cancer or patient outcome was further analyzed, and the factors contributing to disease prognosis were evaluated by multiple Cox models. Stromal NNMT expression was higher in the malignant tissue ( p <0.001). NNMT expression was significantly associated with GC stage ( p =0.006). Compared to stromal "NNMT-low" cases, "NNMT-high" cases has lower disease-specific survival (hazard ratio [HR], 2.356; 95% confidence interval [CI] = 1.591–3.488; p <0.001) and disease-free survival (HR = 2.265; 95% CI = 1.529–3.354; p <0.001), as observed by multivariate Cox analysis after adjusting for stromal NNMT expression with other factors such as tumor grade and size. Notably, patients with stage II NNMT-low GC might be negatively affected by adjuvant chemotherapy, but lower stromal NNMT expression predicted a more favorable prognosis for GC. Our study confirmed that stromal NNMT expression is significantly increased in GC, which predicts an unfavorable post-operative prognosis for GC:
- Is Part Of:
- Journal of histochemistry and cytochemistry. Volume 69:Number 3(2021)
- Journal:
- Journal of histochemistry and cytochemistry
- Issue:
- Volume 69:Number 3(2021)
- Issue Display:
- Volume 69, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 69
- Issue:
- 3
- Issue Sort Value:
- 2021-0069-0003-0000
- Page Start:
- 165
- Page End:
- 176
- Publication Date:
- 2021-03
- Subjects:
- cancer-associated fibroblast -- chemotherapy -- gastric cancer -- immunohistochemistry -- NNMT -- prognosis
Histochemistry -- Periodicals
Cytochemistry -- Periodicals
Histocytochemistry -- methods
Histological Techniques
572.05 - Journal URLs:
- http://www.jhc.org/ ↗
http://journals.sagepub.com/home/jhc ↗
http://www.sagepublications.com/ ↗ - DOI:
- 10.1369/0022155420976590 ↗
- Languages:
- English
- ISSNs:
- 0022-1554
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15024.xml